insulin-like growth factor igf -i igf binding protein num cancer risk systematic review meta-regression analysis pubmed ncbi abstract background insulin-like growth factor igf -i main binding protein igfbp num modulate cell growth survival thought important tumour development circulating concentrations igf-i increased risk cancer igfbp num concentrations decreased cancer risk methods systematic review meta-regression analysis case-control studies including studies nested cohorts association concentrations igf-i igfbp num prostate colorectal premenopausal postmenopausal breast lung cancer study-specific dose-response slopes obtained relating natural log odds ratios exposure levels blood concentrations normalised percentile scale findings identified num eligible studies num datasets included num cases num controls high concentrations igf-i increased risk prostate cancer odds ratio comparing num num percentile num num ci num num premenopausal breast cancer num num num high concentrations igfbp num increased risk premenopausal breast cancer num num num associations larger assessments plasma samples serum samples standard case-control studies compared nested studies interpretation circulating concentrations igf-i igfbp num increased risk common cancers associations modest vary sites laboratory methods standardised epidemiological observations major implications assessment risk prevention cancer 
